SCHEMBL484387

SCHEMBL484387

COc1ccc(C(=O)NC2CCc3ccc(C(=O)N4CCC5(CCN(c6ccncc6)CC5)C4)cc32)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 13/20 0.50
CYP2D6 P10635 4/20 0.50
CYP1A2 P05177 3/20 0.50
CYP2C9 P11712 6/20 0.47
TSHR P16473 4/20 0.47
MAPK1 P28482 1/20 0.47
ITGB3 P05106 2/20 0.41
ITGA2B P08514 2/20 0.41
PDE10A Q9Y233 1/20 0.40
ALDH1A1 P00352 4/20 0.40
HIF1A Q16665 2/20 0.40
USP2 O75604 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 2/20 0.40
JAK2 O60674 1/20 0.40
TYK2 P29597 1/20 0.40
AR P10275 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
TAS1R2 Q8TE23 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484258 1.00 CYP3A4 (0.50) CYP3A4CYP2D6CYP1A2CYP2C9TSHR
SCHEMBL484862 0.96 CYP3A4 (0.53) CYP3A4CYP2D6CYP1A2CYP2C9TSHR
SCHEMBL484308 0.96 CYP3A4 (0.53) CYP3A4CYP2D6CYP1A2CYP2C9TSHR
SCHEMBL484342 0.96 CYP3A4 (0.56) CYP3A4CYP2D6CYP1A2CYP2C9TSHR
SCHEMBL484403 0.94 CYP3A4 (0.52) CYP3A4CYP2D6CYP1A2CYP2C9TSHR
SCHEMBL484656 0.91 CYP3A4 (0.50) CYP3A4CYP2D6CYP1A2CYP2C9TSHR
SCHEMBL484750 0.91 CYP3A4 (0.50) CYP3A4CYP2D6CYP1A2CYP2C9TSHR
SCHEMBL484784 0.90 CYP3A4 (0.43) CYP3A4CYP2D6CYP1A2CYP2C9TSHR
SCHEMBL2816090 0.89 CYP3A4 (0.52) CYP3A4CYP2D6CYP1A2CYP2C9TSHR
SCHEMBL484633 0.89 CYP3A4 (0.47) CYP3A4CYP2D6CYP1A2CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885CYP2D6 1926/4885CYP1A2 3400/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885CYP2D6 1926/4885CYP1A2 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.